We sampled the inferior frontal gyrus because this region is presumably affected by tau aggregates in patients with PiD and FTLD pathologies, as well as in patients with AD at Braak stage V–VI, but not in Braak stage 0–II CTL brains. This evidence concerns the gene MAPT and Alzheimer disease.